325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells
oleh: Joshua Brody, Stephen Willingham, Richard Miller, Thomas Marron, Gerard Criner, Mehrdad Mobasher, Craig Hill, Shenshen Hu, Suresh Mahabhashyam
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.